Aspirin for prevention of cardiovascular events in bipolar disorders

被引：1
|
作者：
Fond, Guillaume [1 ]
Leboyer, Marion [1 ]
Macgregor, Alexandra [2 ]
Girerd, Nicolas [3 ]
机构：
[1] Univ Paris Est Creteil, Pole Psychiat Hop Genet, INSERM U955, Fdn FondaMental Fdn Cooperat, Creteil, France
[2] CHRU Montpellier, Serv Psychiat Univ, INSERM 1061, Colombiere, France
[3] Univ Lorraine, CHU Nancy, Inst Lorrain Coeur & Vaisseaux, INSERM,Ctr Invest Clin 9501, Nancy, France
来源：
PSYCHIATRY RESEARCH | 2014年 / 219卷 / 01期
关键词：
METAANALYSIS; DEPRESSION; ANTIPSYCHOTICS; SCHIZOPHRENIA; MORTALITY; TRIALS; FOCUS;
D O I：
10.1016/j.psychres.2014.05.011
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：238 / 239
页数：2
相关论文
共 50 条
  • [41] Rivaroxaban (Xarelto) plus Aspirin for Secondary Prevention of Cardiovascular Events
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1561): : 196 - 197
  • [42] Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes
    Lacaze, Paul
    Bakshi, Andrew
    Riaz, Moeen
    Polekhina, Galina
    Owen, Alice
    Bhatia, Harpreet S.
    Natarajan, Pradeep
    Wolfe, Rory
    Beilin, Lawrence
    Nicholls, Stephen J.
    Watts, Gerald F.
    McNeil, John J.
    Tonkin, Andrew M.
    Tsimikas, Sotirios
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (14) : 1287 - 1298
  • [43] Chronic aspirin therapy for the prevention of cardiovascular events: a waste of time, or worse?
    Cleland, JGF
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (05): : 234 - 235
  • [44] Chronic aspirin therapy for the prevention of cardiovascular events: a waste of time, or worse?
    John GF Cleland
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 234 - 235
  • [45] ASPIRIN FOR PRIMARY PREVENTION REDUCES CARDIOVASCULAR EVENTS, INCREASES BLEEDING RISK
    Rosenberg, Karen
    AMERICAN JOURNAL OF NURSING, 2019, 119 (05) : 66 - 66
  • [46] Aspirin for Primary Prevention of Cardiovascular Events in Diabetes Still an Open Question
    Nicolucci, Antonio
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (18): : 2180 - 2181
  • [47] An Appraisal of Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Prevention of Cardiovascular Events
    Terpening, Chris
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2009, 22 (01) : 51 - 56
  • [48] Aspirin for the Primary Prevention of Cardiovascular Events: Considerations Regarding the Risk/Benefit
    Franklin, Barry A.
    PHYSICIAN AND SPORTSMEDICINE, 2010, 38 (01): : 158 - 161
  • [49] Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
    Djatche L.M.
    Varga S.
    Lieberthal R.D.
    PharmacoEconomics - Open, 2018, 2 (4) : 371 - 380
  • [50] Aspirin for primary prevention of cardiovascular disease events in diabetes: the balancing act?
    Thabah, M. M.
    Sharma, R.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2018, 48 (04): : 332 - 333
12345